People with MS are advised not to interrupt their immunomodulating drug treatments on account of the COVID-19 pandemic--according to Dr. Robert Fox, one of the leading authorities on MS, who is affiliated with the Cleveland Clinic Neurological Institute and the Mellen Center for MS:
COVID-19: Preventive Measures in Multiple Sclerosis Patients and Others on Immuno-Modulators